New hope drug enters first human tests for tough cancers

NCT ID NCT06662760

Summary

This is a first-in-human study to test the safety and find the right dose of a new drug called TQB3002 for people with advanced cancers. It is for adults whose cancer has continued to grow despite standard treatments or who have no other effective options. The main goals are to see what side effects occur and how much of the drug the body can handle.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center

    NOT_YET_RECRUITING

    Shenzhen, Guangdong, 518117, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guangdong Provincial People's Hospital

    RECRUITING

    Guangzhou, Guangdong, 510180, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Henan Cancer Hospital

    NOT_YET_RECRUITING

    Zhengzhou, Henan, 450003, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Jiangsu Province Hospital

    NOT_YET_RECRUITING

    Nanjing, Jiangsu, 210029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Mianyang Central Hospital

    NOT_YET_RECRUITING

    Mianyang, Sichuan, 621099, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shanghai Pulmonary Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sichuan Cancer Hospital

    NOT_YET_RECRUITING

    Chengdu, Sichuan, 610040, China

    Contact Phone: •••-•••-••••

  • The First Affiliated Hospital Of Nanchang University

    NOT_YET_RECRUITING

    Nanchang, Jiangxi, 330038, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    NOT_YET_RECRUITING

    Xi’an, Shanxi, 710061, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Second Affiliated Hospital of Xi'an Jiaotong University

    NOT_YET_RECRUITING

    Xi’an, Shanxi, 710004, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Yunnan Cancer Hospital

    NOT_YET_RECRUITING

    Kunming, Yunnan, 650118, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.